A bit thick: Hidden risks in thickening products’ labelling for dysphagia treatment

2021 ◽  
pp. 106960
Author(s):  
M. Bolivar-Prados ◽  
N. Tomsen ◽  
C. Arenas ◽  
L. Ibáñez ◽  
P. Clave'
Keyword(s):  
Dysphagia Treatment

Preliminary outcomes in transcutaneous neuromuscular electrical stimulation use in patients with dysphagia

2018 ◽  
Vol 8 (31) ◽  
pp. 167-174
Author(s):  
Codrut Sarafoleanu ◽  
Raluca Enache
Keyword(s):  
Traumatic Brain Injury ◽  
Head And Neck Cancer ◽  
Electrical Stimulation ◽  
Neurodegenerative Disorders ◽  
Structural Changes ◽  
Congenital Abnormalities ◽  
Neuromuscular Electrical Stimulation ◽  
Therapy Options ◽  
Dysphagia Treatment ◽  
Risk Of Aspiration

Abstract Dysphagia is a common disorder associated with a large number of etiologies like aging, stroke, traumatic brain injury, head and neck cancer, neurodegenerative disorders, structural changes or congenital abnormalities. The type of the treatment and its results depend on the type, severity and the cause of dysphagia. The primary goal of dysphagia treatment is to improve the swallowing process and decrease the risk of aspiration. Along with the existing rehabilitation swallowing treatments, new adjunctive therapy options developed, one of them being the neuromuscular electrical stimulation (NMES). The authors present the principles of NMES, a small literature review about the results of this therapy and their experience in using transcutaneous NMES in dysphagia patients.

scholarly journals Therapeutic Approaches to Dysphagia Treatment in Parkinson Disease: A Review

2019 ◽  
Vol 6 (4) ◽  
Author(s):  
Ali Akbar Dashtelei ◽  
Ahmad Reza Khatoonabadi ◽  
Jalal Bakhtiari
Keyword(s):  
Parkinson Disease ◽  
Therapeutic Approaches ◽  
Dysphagia Treatment

scholarly journals Comparison of the Thickeners Used in Dysphagia Treatment

2012 ◽  
Vol 2 (2) ◽  
pp. 67-72 ◽  
Author(s):  
박진우 ◽  
박예슬 ◽  
오금례
Keyword(s):  
Dysphagia Treatment

scholarly journals Protocol for a scoping review study to identify and map treatments for dysphagia following moderate to severe acquired brain injury

BMJ Open ◽  
2019 ◽  
Vol 9 (7) ◽  
pp. e029061
Author(s):  
Signe Janum Eskildsen ◽  
Daniela Jakobsen ◽  
Christian Gunge Riberholt ◽  
Ingrid Poulsen ◽  
Derek John Curtis
Keyword(s):  
Brain Injury ◽  
Scoping Review ◽  
Research Question ◽  
Acquired Brain Injury ◽  
Research Literature ◽  
Cochrane Library ◽  
High Morbidity ◽  
Cochrane Central Register ◽  
Severe Acquired Brain Injury ◽  
Dysphagia Treatment

IntroductionDysphagia is highly prevalent in patients with acquired brain injury (ABI) and is associated with high morbidity and mortality. However, dysphagia management varies greatly between units and internationally, and there is currently no consensus, standard intervention or treatment. A review mapping the existing literature on dysphagia treatment is needed. In this paper, the protocol for a scoping review to identify and map dysphagia treatment following ABI is outlined.ObjectiveThe objective of the scoping review is to systematically map the existing research literature to answer the research question:Which non-surgical, non-pharmacological interventions are used in the treatment of dysphagia in patients with moderate and severe acquired brain injury in the acute and subacute phase?Methods and analysisThe methodological framework for the study is based on methodology by Arksey and O’Malley and methodological advancement by Levacet al. We will search electronic databases in June 2019: MEDLINE (Ovid); Cochrane Central Register of Controlled Trials (CENTRAL, The Cochrane Library); EMBASE (Ovid); CINAHL (EBSCO); PsycINFO; Science Citation Index Expanded on Web of Science; OTseeker; Speechbite and PEDro. The search terms will be limited to patients with moderate to severe ABI and dysphagia. Four review authors will independently conduct an initial screening of title and abstract and subsequent full-text review of included studies. Data will be extracted and summarised in diagrammatic or tabular form (numerical summary), and a descriptive format (narrative summary). The strategy for data synthesis entails qualitative methods to categorise the interventions based on the treatment modality and subgroup diagnosis.Ethics and disseminationScoping the existing literature will provide a foundation for further evaluating and developing our dysphagia treatment and inform future studies assessing the effectiveness of treatments. The review is part of an ongoing expansive research into dysphagia. The results will be disseminated through a peer-reviewed publication and conference presentations.

Electrical pharyngeal stimulation for dysphagia treatment in tracheotomized stroke patients: a randomized controlled trial

2015 ◽  
Vol 41 (9) ◽  
pp. 1629-1637 ◽  
Author(s):  
Sonja Suntrup ◽  
Thomas Marian ◽  
Jens Burchard Schröder ◽  
Inga Suttrup ◽  
Paul Muhle ◽  
...  
Keyword(s):  
Randomized Controlled Trial ◽  
Controlled Trial ◽  
Stroke Patients ◽  
Randomized Controlled ◽  
Dysphagia Treatment

Drug-Induced Esophageal Injury: A Case Report of Percogesic

DICP ◽  
1989 ◽  
Vol 23 (3) ◽  
pp. 227-229 ◽  
Author(s):  
Patrick E. Nwakama ◽  
Harry J. Jenkins ◽  
Robert T. Bailey ◽  
John Pelligrino ◽  
Tom R. Demeester ◽  
...  
Keyword(s):  
Case Report ◽  
Mucosal Injury ◽  
Upright Position ◽  
Esophageal Injury ◽  
Upper Gastrointestinal Endoscopy ◽  
Drug Induced ◽  
First Case ◽  
Retrosternal Pain ◽  
Deep Ulceration ◽  
Dysphagia Treatment

This is the first case report of esophageal injury caused by Percogesic. A 31-year-old healthy white woman presented with dysphagia and retrosternal pain following the ingestion of a Percogesic tablet. The patient felt the tablet lodge in her mid-esophagus even though she ingested it with a cupful of water and in the upright position. Additional fluid was taken to dislodge the tablet with no success. Past medical history was unremarkable for heartburn, regurgitation, or dysphagia. Upper gastrointestinal endoscopy revealed a well-circumscribed deep ulceration in the mid-esophagus. Hospitalization was required due to persistent dysphagia. Treatment consisted of a three-day regimen of liquid antacid, intravenous ranitidine hydrochloride, and metoclopramide. This case emphasizes that pill entrapment can occur in the esophagus in healthy individuals, even when taken in the upright position with plenty of fluid; and mucosal injury can be produced by drugs not generally reported to cause gastrointestinal adverse effects or mucosal injury.

Sign in / Sign up

Export Citation Format

Share Document